Global Allergy Medications Market

Allergy Medications Comprehensive Study by Type (Pills, Liquids, Inhalers, Nasal Sprays, Eyedrops, Skin Creams, Others), End-users (Hospitals, Clinics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmaciees, Online, Others) Players and Region - Global Market Outlook to 2026

Allergy Medications Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Allergy Medications Market?

An allergy is an immune system response to a foreign substance such as foods, furry animal dander, or pollen that’s not typically harmful to your body. Several types of medications are used to treat allergy symptoms such as pills, liquids, inhalers, nasal sprays, eye drops, skin creams and shots (injections). The factors such as Increasing Prevalence of Various type of Allergies among People and Increased Number of Diagnostic Centres driving the global allergy medications market.

The market study is being classified by Type (Pills, Liquids, Inhalers, Nasal Sprays, Eyedrops, Skin Creams and Others) and major geographies with country level break-up.

Allergy Therapeutics (United Kingdom), Meda Pharmaceuticals, Inc (United States), McNeil Consumer Healthcare (United States), Allergopharma GmbH & Co. KG (Germany), Allergon AB (Sweden), Collegium Pharmaceutical, Inc. (United States), Allergan, Inc. (Ireland), Genentech Inc. (United States), Schering-Plough Corporation (United States) and Sunovion Pharmaceuticals Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Novartis AG (Switzerland) and Circassia Pharmaceuticals (United Kingdom).

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Allergy Medications market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Allergy Medications market by Type, Application and Region.

On the basis of geography, the market of Allergy Medications has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Prevalence of Various type of Allergies among People
  • Increased Number of Diagnostic Centres

Market Trend
  • Growing Demand for Advanced Therapy for Allergy Treatment
  • Rising Demand for Ayurvedic Medicines

Restraints
  • Side Effects of the Allergy Medications

Opportunities
  • Growth in the Healthcare Industry
  • Increasing Awareness among People

Challenges
  • Stringent Government Rules and Regulations among People





Key Target Audience
Allergy Medications Manufacturers, Distributors, Emerging Companies, Research Professionals and End-users

Report Objectives / Segmentation Covered

By Type
  • Pills
  • Liquids
  • Inhalers
  • Nasal Sprays
  • Eyedrops
  • Skin Creams
  • Others
By End-users
  • Hospitals
  • Clinics
  • Others

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmaciees
  • Online
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Various type of Allergies among People
      • 3.2.2. Increased Number of Diagnostic Centres
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations among People
    • 3.4. Market Trends
      • 3.4.1. Growing Demand for Advanced Therapy for Allergy Treatment
      • 3.4.2. Rising Demand for Ayurvedic Medicines
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Allergy Medications, by Type, End-users, Distribution Channel and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Allergy Medications (Value)
      • 5.2.1. Global Allergy Medications by: Type (Value)
        • 5.2.1.1. Pills
        • 5.2.1.2. Liquids
        • 5.2.1.3. Inhalers
        • 5.2.1.4. Nasal Sprays
        • 5.2.1.5. Eyedrops
        • 5.2.1.6. Skin Creams
        • 5.2.1.7. Others
      • 5.2.2. Global Allergy Medications by: End-users (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Others
      • 5.2.3. Global Allergy Medications by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacies
        • 5.2.3.2. Retail Pharmaciees
        • 5.2.3.3. Online
        • 5.2.3.4. Others
      • 5.2.4. Global Allergy Medications Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Allergy Medications (Volume)
      • 5.3.1. Global Allergy Medications by: Type (Volume)
        • 5.3.1.1. Pills
        • 5.3.1.2. Liquids
        • 5.3.1.3. Inhalers
        • 5.3.1.4. Nasal Sprays
        • 5.3.1.5. Eyedrops
        • 5.3.1.6. Skin Creams
        • 5.3.1.7. Others
      • 5.3.2. Global Allergy Medications by: End-users (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Others
      • 5.3.3. Global Allergy Medications by: Distribution Channel (Volume)
        • 5.3.3.1. Hospital Pharmacies
        • 5.3.3.2. Retail Pharmaciees
        • 5.3.3.3. Online
        • 5.3.3.4. Others
      • 5.3.4. Global Allergy Medications Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Allergy Medications (Price)
      • 5.4.1. Global Allergy Medications by: Type (Price)
  • 6. Allergy Medications: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Allergy Therapeutics (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Meda Pharmaceuticals, Inc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. McNeil Consumer Healthcare (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Allergopharma GmbH & Co. KG (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Allergon AB (Sweden)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Collegium Pharmaceutical, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Allergan, Inc. (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Genentech Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Schering-Plough Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sunovion Pharmaceuticals Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Allergy Medications Sale, by Type, End-users, Distribution Channel and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Allergy Medications (Value)
      • 7.2.1. Global Allergy Medications by: Type (Value)
        • 7.2.1.1. Pills
        • 7.2.1.2. Liquids
        • 7.2.1.3. Inhalers
        • 7.2.1.4. Nasal Sprays
        • 7.2.1.5. Eyedrops
        • 7.2.1.6. Skin Creams
        • 7.2.1.7. Others
      • 7.2.2. Global Allergy Medications by: End-users (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Others
      • 7.2.3. Global Allergy Medications by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacies
        • 7.2.3.2. Retail Pharmaciees
        • 7.2.3.3. Online
        • 7.2.3.4. Others
      • 7.2.4. Global Allergy Medications Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Allergy Medications (Volume)
      • 7.3.1. Global Allergy Medications by: Type (Volume)
        • 7.3.1.1. Pills
        • 7.3.1.2. Liquids
        • 7.3.1.3. Inhalers
        • 7.3.1.4. Nasal Sprays
        • 7.3.1.5. Eyedrops
        • 7.3.1.6. Skin Creams
        • 7.3.1.7. Others
      • 7.3.2. Global Allergy Medications by: End-users (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Others
      • 7.3.3. Global Allergy Medications by: Distribution Channel (Volume)
        • 7.3.3.1. Hospital Pharmacies
        • 7.3.3.2. Retail Pharmaciees
        • 7.3.3.3. Online
        • 7.3.3.4. Others
      • 7.3.4. Global Allergy Medications Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Allergy Medications (Price)
      • 7.4.1. Global Allergy Medications by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Allergy Medications: by Type(USD Million)
  • Table 2. Allergy Medications Pills , by Region USD Million (2015-2020)
  • Table 3. Allergy Medications Liquids , by Region USD Million (2015-2020)
  • Table 4. Allergy Medications Inhalers , by Region USD Million (2015-2020)
  • Table 5. Allergy Medications Nasal Sprays , by Region USD Million (2015-2020)
  • Table 6. Allergy Medications Eyedrops , by Region USD Million (2015-2020)
  • Table 7. Allergy Medications Skin Creams , by Region USD Million (2015-2020)
  • Table 8. Allergy Medications Others , by Region USD Million (2015-2020)
  • Table 9. Allergy Medications: by End-users(USD Million)
  • Table 10. Allergy Medications Hospitals , by Region USD Million (2015-2020)
  • Table 11. Allergy Medications Clinics , by Region USD Million (2015-2020)
  • Table 12. Allergy Medications Others , by Region USD Million (2015-2020)
  • Table 13. Allergy Medications: by Distribution Channel(USD Million)
  • Table 14. Allergy Medications Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 15. Allergy Medications Retail Pharmaciees , by Region USD Million (2015-2020)
  • Table 16. Allergy Medications Online , by Region USD Million (2015-2020)
  • Table 17. Allergy Medications Others , by Region USD Million (2015-2020)
  • Table 18. South America Allergy Medications, by Country USD Million (2015-2020)
  • Table 19. South America Allergy Medications, by Type USD Million (2015-2020)
  • Table 20. South America Allergy Medications, by End-users USD Million (2015-2020)
  • Table 21. South America Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 22. Brazil Allergy Medications, by Type USD Million (2015-2020)
  • Table 23. Brazil Allergy Medications, by End-users USD Million (2015-2020)
  • Table 24. Brazil Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 25. Argentina Allergy Medications, by Type USD Million (2015-2020)
  • Table 26. Argentina Allergy Medications, by End-users USD Million (2015-2020)
  • Table 27. Argentina Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 28. Rest of South America Allergy Medications, by Type USD Million (2015-2020)
  • Table 29. Rest of South America Allergy Medications, by End-users USD Million (2015-2020)
  • Table 30. Rest of South America Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 31. Asia Pacific Allergy Medications, by Country USD Million (2015-2020)
  • Table 32. Asia Pacific Allergy Medications, by Type USD Million (2015-2020)
  • Table 33. Asia Pacific Allergy Medications, by End-users USD Million (2015-2020)
  • Table 34. Asia Pacific Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 35. China Allergy Medications, by Type USD Million (2015-2020)
  • Table 36. China Allergy Medications, by End-users USD Million (2015-2020)
  • Table 37. China Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 38. Japan Allergy Medications, by Type USD Million (2015-2020)
  • Table 39. Japan Allergy Medications, by End-users USD Million (2015-2020)
  • Table 40. Japan Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 41. India Allergy Medications, by Type USD Million (2015-2020)
  • Table 42. India Allergy Medications, by End-users USD Million (2015-2020)
  • Table 43. India Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 44. South Korea Allergy Medications, by Type USD Million (2015-2020)
  • Table 45. South Korea Allergy Medications, by End-users USD Million (2015-2020)
  • Table 46. South Korea Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 47. Taiwan Allergy Medications, by Type USD Million (2015-2020)
  • Table 48. Taiwan Allergy Medications, by End-users USD Million (2015-2020)
  • Table 49. Taiwan Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 50. Australia Allergy Medications, by Type USD Million (2015-2020)
  • Table 51. Australia Allergy Medications, by End-users USD Million (2015-2020)
  • Table 52. Australia Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Allergy Medications, by Type USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Allergy Medications, by End-users USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 56. Europe Allergy Medications, by Country USD Million (2015-2020)
  • Table 57. Europe Allergy Medications, by Type USD Million (2015-2020)
  • Table 58. Europe Allergy Medications, by End-users USD Million (2015-2020)
  • Table 59. Europe Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 60. Germany Allergy Medications, by Type USD Million (2015-2020)
  • Table 61. Germany Allergy Medications, by End-users USD Million (2015-2020)
  • Table 62. Germany Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 63. France Allergy Medications, by Type USD Million (2015-2020)
  • Table 64. France Allergy Medications, by End-users USD Million (2015-2020)
  • Table 65. France Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 66. Italy Allergy Medications, by Type USD Million (2015-2020)
  • Table 67. Italy Allergy Medications, by End-users USD Million (2015-2020)
  • Table 68. Italy Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 69. United Kingdom Allergy Medications, by Type USD Million (2015-2020)
  • Table 70. United Kingdom Allergy Medications, by End-users USD Million (2015-2020)
  • Table 71. United Kingdom Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 72. Netherlands Allergy Medications, by Type USD Million (2015-2020)
  • Table 73. Netherlands Allergy Medications, by End-users USD Million (2015-2020)
  • Table 74. Netherlands Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 75. Rest of Europe Allergy Medications, by Type USD Million (2015-2020)
  • Table 76. Rest of Europe Allergy Medications, by End-users USD Million (2015-2020)
  • Table 77. Rest of Europe Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 78. MEA Allergy Medications, by Country USD Million (2015-2020)
  • Table 79. MEA Allergy Medications, by Type USD Million (2015-2020)
  • Table 80. MEA Allergy Medications, by End-users USD Million (2015-2020)
  • Table 81. MEA Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 82. Middle East Allergy Medications, by Type USD Million (2015-2020)
  • Table 83. Middle East Allergy Medications, by End-users USD Million (2015-2020)
  • Table 84. Middle East Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 85. Africa Allergy Medications, by Type USD Million (2015-2020)
  • Table 86. Africa Allergy Medications, by End-users USD Million (2015-2020)
  • Table 87. Africa Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 88. North America Allergy Medications, by Country USD Million (2015-2020)
  • Table 89. North America Allergy Medications, by Type USD Million (2015-2020)
  • Table 90. North America Allergy Medications, by End-users USD Million (2015-2020)
  • Table 91. North America Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 92. United States Allergy Medications, by Type USD Million (2015-2020)
  • Table 93. United States Allergy Medications, by End-users USD Million (2015-2020)
  • Table 94. United States Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 95. Canada Allergy Medications, by Type USD Million (2015-2020)
  • Table 96. Canada Allergy Medications, by End-users USD Million (2015-2020)
  • Table 97. Canada Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 98. Mexico Allergy Medications, by Type USD Million (2015-2020)
  • Table 99. Mexico Allergy Medications, by End-users USD Million (2015-2020)
  • Table 100. Mexico Allergy Medications, by Distribution Channel USD Million (2015-2020)
  • Table 101. Allergy Medications Sales: by Type(K Units)
  • Table 102. Allergy Medications Sales Pills , by Region K Units (2015-2020)
  • Table 103. Allergy Medications Sales Liquids , by Region K Units (2015-2020)
  • Table 104. Allergy Medications Sales Inhalers , by Region K Units (2015-2020)
  • Table 105. Allergy Medications Sales Nasal Sprays , by Region K Units (2015-2020)
  • Table 106. Allergy Medications Sales Eyedrops , by Region K Units (2015-2020)
  • Table 107. Allergy Medications Sales Skin Creams , by Region K Units (2015-2020)
  • Table 108. Allergy Medications Sales Others , by Region K Units (2015-2020)
  • Table 109. Allergy Medications Sales: by End-users(K Units)
  • Table 110. Allergy Medications Sales Hospitals , by Region K Units (2015-2020)
  • Table 111. Allergy Medications Sales Clinics , by Region K Units (2015-2020)
  • Table 112. Allergy Medications Sales Others , by Region K Units (2015-2020)
  • Table 113. Allergy Medications Sales: by Distribution Channel(K Units)
  • Table 114. Allergy Medications Sales Hospital Pharmacies , by Region K Units (2015-2020)
  • Table 115. Allergy Medications Sales Retail Pharmaciees , by Region K Units (2015-2020)
  • Table 116. Allergy Medications Sales Online , by Region K Units (2015-2020)
  • Table 117. Allergy Medications Sales Others , by Region K Units (2015-2020)
  • Table 118. South America Allergy Medications Sales, by Country K Units (2015-2020)
  • Table 119. South America Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 120. South America Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 121. South America Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 122. Brazil Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 123. Brazil Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 124. Brazil Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 125. Argentina Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 126. Argentina Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 127. Argentina Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 128. Rest of South America Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 129. Rest of South America Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 130. Rest of South America Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 131. Asia Pacific Allergy Medications Sales, by Country K Units (2015-2020)
  • Table 132. Asia Pacific Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 133. Asia Pacific Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 134. Asia Pacific Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 135. China Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 136. China Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 137. China Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 138. Japan Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 139. Japan Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 140. Japan Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 141. India Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 142. India Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 143. India Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 144. South Korea Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 145. South Korea Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 146. South Korea Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 147. Taiwan Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 148. Taiwan Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 149. Taiwan Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 150. Australia Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 151. Australia Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 152. Australia Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 153. Rest of Asia-Pacific Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 154. Rest of Asia-Pacific Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 155. Rest of Asia-Pacific Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 156. Europe Allergy Medications Sales, by Country K Units (2015-2020)
  • Table 157. Europe Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 158. Europe Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 159. Europe Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 160. Germany Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 161. Germany Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 162. Germany Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 163. France Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 164. France Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 165. France Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 166. Italy Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 167. Italy Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 168. Italy Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 169. United Kingdom Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 170. United Kingdom Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 171. United Kingdom Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 172. Netherlands Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 173. Netherlands Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 174. Netherlands Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 175. Rest of Europe Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 176. Rest of Europe Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 177. Rest of Europe Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 178. MEA Allergy Medications Sales, by Country K Units (2015-2020)
  • Table 179. MEA Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 180. MEA Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 181. MEA Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 182. Middle East Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 183. Middle East Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 184. Middle East Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 185. Africa Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 186. Africa Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 187. Africa Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 188. North America Allergy Medications Sales, by Country K Units (2015-2020)
  • Table 189. North America Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 190. North America Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 191. North America Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 192. United States Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 193. United States Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 194. United States Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 195. Canada Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 196. Canada Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 197. Canada Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 198. Mexico Allergy Medications Sales, by Type K Units (2015-2020)
  • Table 199. Mexico Allergy Medications Sales, by End-users K Units (2015-2020)
  • Table 200. Mexico Allergy Medications Sales, by Distribution Channel K Units (2015-2020)
  • Table 201. Allergy Medications: by Type(USD/Units)
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Allergy Medications: by Type(USD Million)
  • Table 213. Allergy Medications Pills , by Region USD Million (2021-2026)
  • Table 214. Allergy Medications Liquids , by Region USD Million (2021-2026)
  • Table 215. Allergy Medications Inhalers , by Region USD Million (2021-2026)
  • Table 216. Allergy Medications Nasal Sprays , by Region USD Million (2021-2026)
  • Table 217. Allergy Medications Eyedrops , by Region USD Million (2021-2026)
  • Table 218. Allergy Medications Skin Creams , by Region USD Million (2021-2026)
  • Table 219. Allergy Medications Others , by Region USD Million (2021-2026)
  • Table 220. Allergy Medications: by End-users(USD Million)
  • Table 221. Allergy Medications Hospitals , by Region USD Million (2021-2026)
  • Table 222. Allergy Medications Clinics , by Region USD Million (2021-2026)
  • Table 223. Allergy Medications Others , by Region USD Million (2021-2026)
  • Table 224. Allergy Medications: by Distribution Channel(USD Million)
  • Table 225. Allergy Medications Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 226. Allergy Medications Retail Pharmaciees , by Region USD Million (2021-2026)
  • Table 227. Allergy Medications Online , by Region USD Million (2021-2026)
  • Table 228. Allergy Medications Others , by Region USD Million (2021-2026)
  • Table 229. South America Allergy Medications, by Country USD Million (2021-2026)
  • Table 230. South America Allergy Medications, by Type USD Million (2021-2026)
  • Table 231. South America Allergy Medications, by End-users USD Million (2021-2026)
  • Table 232. South America Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 233. Brazil Allergy Medications, by Type USD Million (2021-2026)
  • Table 234. Brazil Allergy Medications, by End-users USD Million (2021-2026)
  • Table 235. Brazil Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 236. Argentina Allergy Medications, by Type USD Million (2021-2026)
  • Table 237. Argentina Allergy Medications, by End-users USD Million (2021-2026)
  • Table 238. Argentina Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 239. Rest of South America Allergy Medications, by Type USD Million (2021-2026)
  • Table 240. Rest of South America Allergy Medications, by End-users USD Million (2021-2026)
  • Table 241. Rest of South America Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 242. Asia Pacific Allergy Medications, by Country USD Million (2021-2026)
  • Table 243. Asia Pacific Allergy Medications, by Type USD Million (2021-2026)
  • Table 244. Asia Pacific Allergy Medications, by End-users USD Million (2021-2026)
  • Table 245. Asia Pacific Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 246. China Allergy Medications, by Type USD Million (2021-2026)
  • Table 247. China Allergy Medications, by End-users USD Million (2021-2026)
  • Table 248. China Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 249. Japan Allergy Medications, by Type USD Million (2021-2026)
  • Table 250. Japan Allergy Medications, by End-users USD Million (2021-2026)
  • Table 251. Japan Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 252. India Allergy Medications, by Type USD Million (2021-2026)
  • Table 253. India Allergy Medications, by End-users USD Million (2021-2026)
  • Table 254. India Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 255. South Korea Allergy Medications, by Type USD Million (2021-2026)
  • Table 256. South Korea Allergy Medications, by End-users USD Million (2021-2026)
  • Table 257. South Korea Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 258. Taiwan Allergy Medications, by Type USD Million (2021-2026)
  • Table 259. Taiwan Allergy Medications, by End-users USD Million (2021-2026)
  • Table 260. Taiwan Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 261. Australia Allergy Medications, by Type USD Million (2021-2026)
  • Table 262. Australia Allergy Medications, by End-users USD Million (2021-2026)
  • Table 263. Australia Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 264. Rest of Asia-Pacific Allergy Medications, by Type USD Million (2021-2026)
  • Table 265. Rest of Asia-Pacific Allergy Medications, by End-users USD Million (2021-2026)
  • Table 266. Rest of Asia-Pacific Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 267. Europe Allergy Medications, by Country USD Million (2021-2026)
  • Table 268. Europe Allergy Medications, by Type USD Million (2021-2026)
  • Table 269. Europe Allergy Medications, by End-users USD Million (2021-2026)
  • Table 270. Europe Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 271. Germany Allergy Medications, by Type USD Million (2021-2026)
  • Table 272. Germany Allergy Medications, by End-users USD Million (2021-2026)
  • Table 273. Germany Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 274. France Allergy Medications, by Type USD Million (2021-2026)
  • Table 275. France Allergy Medications, by End-users USD Million (2021-2026)
  • Table 276. France Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 277. Italy Allergy Medications, by Type USD Million (2021-2026)
  • Table 278. Italy Allergy Medications, by End-users USD Million (2021-2026)
  • Table 279. Italy Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 280. United Kingdom Allergy Medications, by Type USD Million (2021-2026)
  • Table 281. United Kingdom Allergy Medications, by End-users USD Million (2021-2026)
  • Table 282. United Kingdom Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 283. Netherlands Allergy Medications, by Type USD Million (2021-2026)
  • Table 284. Netherlands Allergy Medications, by End-users USD Million (2021-2026)
  • Table 285. Netherlands Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 286. Rest of Europe Allergy Medications, by Type USD Million (2021-2026)
  • Table 287. Rest of Europe Allergy Medications, by End-users USD Million (2021-2026)
  • Table 288. Rest of Europe Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 289. MEA Allergy Medications, by Country USD Million (2021-2026)
  • Table 290. MEA Allergy Medications, by Type USD Million (2021-2026)
  • Table 291. MEA Allergy Medications, by End-users USD Million (2021-2026)
  • Table 292. MEA Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 293. Middle East Allergy Medications, by Type USD Million (2021-2026)
  • Table 294. Middle East Allergy Medications, by End-users USD Million (2021-2026)
  • Table 295. Middle East Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 296. Africa Allergy Medications, by Type USD Million (2021-2026)
  • Table 297. Africa Allergy Medications, by End-users USD Million (2021-2026)
  • Table 298. Africa Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 299. North America Allergy Medications, by Country USD Million (2021-2026)
  • Table 300. North America Allergy Medications, by Type USD Million (2021-2026)
  • Table 301. North America Allergy Medications, by End-users USD Million (2021-2026)
  • Table 302. North America Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 303. United States Allergy Medications, by Type USD Million (2021-2026)
  • Table 304. United States Allergy Medications, by End-users USD Million (2021-2026)
  • Table 305. United States Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 306. Canada Allergy Medications, by Type USD Million (2021-2026)
  • Table 307. Canada Allergy Medications, by End-users USD Million (2021-2026)
  • Table 308. Canada Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 309. Mexico Allergy Medications, by Type USD Million (2021-2026)
  • Table 310. Mexico Allergy Medications, by End-users USD Million (2021-2026)
  • Table 311. Mexico Allergy Medications, by Distribution Channel USD Million (2021-2026)
  • Table 312. Allergy Medications Sales: by Type(K Units)
  • Table 313. Allergy Medications Sales Pills , by Region K Units (2021-2026)
  • Table 314. Allergy Medications Sales Liquids , by Region K Units (2021-2026)
  • Table 315. Allergy Medications Sales Inhalers , by Region K Units (2021-2026)
  • Table 316. Allergy Medications Sales Nasal Sprays , by Region K Units (2021-2026)
  • Table 317. Allergy Medications Sales Eyedrops , by Region K Units (2021-2026)
  • Table 318. Allergy Medications Sales Skin Creams , by Region K Units (2021-2026)
  • Table 319. Allergy Medications Sales Others , by Region K Units (2021-2026)
  • Table 320. Allergy Medications Sales: by End-users(K Units)
  • Table 321. Allergy Medications Sales Hospitals , by Region K Units (2021-2026)
  • Table 322. Allergy Medications Sales Clinics , by Region K Units (2021-2026)
  • Table 323. Allergy Medications Sales Others , by Region K Units (2021-2026)
  • Table 324. Allergy Medications Sales: by Distribution Channel(K Units)
  • Table 325. Allergy Medications Sales Hospital Pharmacies , by Region K Units (2021-2026)
  • Table 326. Allergy Medications Sales Retail Pharmaciees , by Region K Units (2021-2026)
  • Table 327. Allergy Medications Sales Online , by Region K Units (2021-2026)
  • Table 328. Allergy Medications Sales Others , by Region K Units (2021-2026)
  • Table 329. South America Allergy Medications Sales, by Country K Units (2021-2026)
  • Table 330. South America Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 331. South America Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 332. South America Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 333. Brazil Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 334. Brazil Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 335. Brazil Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 336. Argentina Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 337. Argentina Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 338. Argentina Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 339. Rest of South America Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 340. Rest of South America Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 341. Rest of South America Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 342. Asia Pacific Allergy Medications Sales, by Country K Units (2021-2026)
  • Table 343. Asia Pacific Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 344. Asia Pacific Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 345. Asia Pacific Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 346. China Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 347. China Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 348. China Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 349. Japan Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 350. Japan Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 351. Japan Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 352. India Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 353. India Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 354. India Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 355. South Korea Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 356. South Korea Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 357. South Korea Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 358. Taiwan Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 359. Taiwan Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 360. Taiwan Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 361. Australia Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 362. Australia Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 363. Australia Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 364. Rest of Asia-Pacific Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 365. Rest of Asia-Pacific Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 366. Rest of Asia-Pacific Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 367. Europe Allergy Medications Sales, by Country K Units (2021-2026)
  • Table 368. Europe Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 369. Europe Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 370. Europe Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 371. Germany Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 372. Germany Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 373. Germany Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 374. France Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 375. France Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 376. France Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 377. Italy Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 378. Italy Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 379. Italy Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 380. United Kingdom Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 381. United Kingdom Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 382. United Kingdom Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 383. Netherlands Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 384. Netherlands Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 385. Netherlands Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 386. Rest of Europe Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 387. Rest of Europe Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 388. Rest of Europe Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 389. MEA Allergy Medications Sales, by Country K Units (2021-2026)
  • Table 390. MEA Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 391. MEA Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 392. MEA Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 393. Middle East Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 394. Middle East Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 395. Middle East Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 396. Africa Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 397. Africa Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 398. Africa Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 399. North America Allergy Medications Sales, by Country K Units (2021-2026)
  • Table 400. North America Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 401. North America Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 402. North America Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 403. United States Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 404. United States Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 405. United States Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 406. Canada Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 407. Canada Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 408. Canada Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 409. Mexico Allergy Medications Sales, by Type K Units (2021-2026)
  • Table 410. Mexico Allergy Medications Sales, by End-users K Units (2021-2026)
  • Table 411. Mexico Allergy Medications Sales, by Distribution Channel K Units (2021-2026)
  • Table 412. Allergy Medications: by Type(USD/Units)
  • Table 413. Research Programs/Design for This Report
  • Table 414. Key Data Information from Secondary Sources
  • Table 415. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Allergy Medications: by Type USD Million (2015-2020)
  • Figure 5. Global Allergy Medications: by End-users USD Million (2015-2020)
  • Figure 6. Global Allergy Medications: by Distribution Channel USD Million (2015-2020)
  • Figure 7. South America Allergy Medications Share (%), by Country
  • Figure 8. Asia Pacific Allergy Medications Share (%), by Country
  • Figure 9. Europe Allergy Medications Share (%), by Country
  • Figure 10. MEA Allergy Medications Share (%), by Country
  • Figure 11. North America Allergy Medications Share (%), by Country
  • Figure 12. Global Allergy Medications: by Type K Units (2015-2020)
  • Figure 13. Global Allergy Medications: by End-users K Units (2015-2020)
  • Figure 14. Global Allergy Medications: by Distribution Channel K Units (2015-2020)
  • Figure 15. South America Allergy Medications Share (%), by Country
  • Figure 16. Asia Pacific Allergy Medications Share (%), by Country
  • Figure 17. Europe Allergy Medications Share (%), by Country
  • Figure 18. MEA Allergy Medications Share (%), by Country
  • Figure 19. North America Allergy Medications Share (%), by Country
  • Figure 20. Global Allergy Medications: by Type USD/Units (2015-2020)
  • Figure 21. Global Allergy Medications share by Players 2020 (%)
  • Figure 22. Global Allergy Medications share by Players (Top 3) 2020(%)
  • Figure 23. Global Allergy Medications share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Allergy Therapeutics (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. Allergy Therapeutics (United Kingdom) Revenue: by Geography 2020
  • Figure 27. Meda Pharmaceuticals, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 28. Meda Pharmaceuticals, Inc (United States) Revenue: by Geography 2020
  • Figure 29. McNeil Consumer Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 30. McNeil Consumer Healthcare (United States) Revenue: by Geography 2020
  • Figure 31. Allergopharma GmbH & Co. KG (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Allergopharma GmbH & Co. KG (Germany) Revenue: by Geography 2020
  • Figure 33. Allergon AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 34. Allergon AB (Sweden) Revenue: by Geography 2020
  • Figure 35. Collegium Pharmaceutical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Collegium Pharmaceutical, Inc. (United States) Revenue: by Geography 2020
  • Figure 37. Allergan, Inc. (Ireland) Revenue, Net Income and Gross profit
  • Figure 38. Allergan, Inc. (Ireland) Revenue: by Geography 2020
  • Figure 39. Genentech Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Genentech Inc. (United States) Revenue: by Geography 2020
  • Figure 41. Schering-Plough Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 42. Schering-Plough Corporation (United States) Revenue: by Geography 2020
  • Figure 43. Sunovion Pharmaceuticals Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Sunovion Pharmaceuticals Inc. (United States) Revenue: by Geography 2020
  • Figure 45. Global Allergy Medications: by Type USD Million (2021-2026)
  • Figure 46. Global Allergy Medications: by End-users USD Million (2021-2026)
  • Figure 47. Global Allergy Medications: by Distribution Channel USD Million (2021-2026)
  • Figure 48. South America Allergy Medications Share (%), by Country
  • Figure 49. Asia Pacific Allergy Medications Share (%), by Country
  • Figure 50. Europe Allergy Medications Share (%), by Country
  • Figure 51. MEA Allergy Medications Share (%), by Country
  • Figure 52. North America Allergy Medications Share (%), by Country
  • Figure 53. Global Allergy Medications: by Type K Units (2021-2026)
  • Figure 54. Global Allergy Medications: by End-users K Units (2021-2026)
  • Figure 55. Global Allergy Medications: by Distribution Channel K Units (2021-2026)
  • Figure 56. South America Allergy Medications Share (%), by Country
  • Figure 57. Asia Pacific Allergy Medications Share (%), by Country
  • Figure 58. Europe Allergy Medications Share (%), by Country
  • Figure 59. MEA Allergy Medications Share (%), by Country
  • Figure 60. North America Allergy Medications Share (%), by Country
  • Figure 61. Global Allergy Medications: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Allergy Therapeutics (United Kingdom)
  • Meda Pharmaceuticals, Inc (United States)
  • McNeil Consumer Healthcare (United States)
  • Allergopharma GmbH & Co. KG (Germany)
  • Allergon AB (Sweden)
  • Collegium Pharmaceutical, Inc. (United States)
  • Allergan, Inc. (Ireland)
  • Genentech Inc. (United States)
  • Schering-Plough Corporation (United States)
  • Sunovion Pharmaceuticals Inc. (United States)
Additional players considered in the study are as follows:
Novartis AG (Switzerland) , Circassia Pharmaceuticals (United Kingdom)
Select User Access Type

Key Highlights of Report


Jan 2022 210 Pages 51 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Allergy Medications Market Quantitative research analysis
Global Allergy Medications Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increasing Prevalence of Various type of Allergies among People " is seen as one of major growth factors of Allergy Medications Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
United States will lead Allergy Medications Market in coming years.

Know More About Global Allergy Medications Market Report?

Have a Query? Click Here

Other Related Reports

Osteonecrosis Comprehensive Study by Application (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers), Diagnoses Used (X-Ray, MRI, Bone Scans, Ct Scan, Surgical Procedures), Route of Administ...
$ 3750
Influenza Treatment Comprehensive Study by Type (Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil, Others), Diagnostic Tests (Viral culture, Serology, Rapid antigen testing, Reverse tr...
$ 3750
Topical Use Acne Treatment Comprehensive Study by Type (Inflammatory Acne, Cystic Acne, Post-Surgical/Wound Acne), Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Drug Type (...
$ 3750
Sacroiliitis Treatment Comprehensive Study by Type (Medication, Pain relievers, Muscle relaxants, TNF inhibitors, Joint Injections, Radiofrequency denervation, Electrical stimulation, Joint fusion), ...
$ 3450
Leishmaniasis Treatment Comprehensive Study by Application (Cutaneous leishmaniasis, Visceral leishmaniasis, Mucocutaneous leishmaniasis), Drug Type (Pentavalent antimonials (Sodium stibogluconate, S...
$ 3750
Phage Therapy Comprehensive Study by Application (Diagnostic, Antimicrobial Drug Discovery, Veterinary Medicines, Others), Route of Administration (Oral, Topical), Targeted Bacteria (Escherichia coli...
$ 3750